ArticleCancer reports (Hoboken, N.J.)2022

Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients.

Einat Shacham Shmueli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.